Cardiac Catheterization Market Research Report Forecast to 2027

Cardiac Catheterization Market: By Procedure (Coronary Angioplasty, Balloon Septostomy), Types (Coronary Angiogram, Fractional Flow Reserve), Application (Heart Attack, Abnormal Stress Test), and End-User (Hospitals & Clinics) – Global Forecast Till 2027

ID: MRFR/MED/0466-HCR | February 2021 | Region: Global | 115 pages         

Cardiac Catheterization Market

The cardiac catheterization market is anticipated to grow at USD 13.34 Billion at a 7.8% CAGR from 2022-2030

Segmentation

By Types Fractional Flow Reserve Optical Coherence Tomography Intravascular Ultrasound Coronary Angiogram
By Procedures Catheter Ablation Coronary Angioplasty Bipolar Pacing Balloon septostomy Right Heart Catheterization Left Heart Catheterization Others
By Application Heart Attack Cardiac Arrhythmia Coronary Vasospasm Abnormal Stress Test Others
By End-user Hospitals & clinics Others

Key Players

  • Jude Medical (US)
  • Medtronic Inc. (US)
  • Becton
  • Dickinson and Company (US)
  • Terumo Medical Corporation (Japan)
  • Teleflex Incorporated (US)
  • Edwards Life Sciences Corporation (US)
  • Abbott (US)
  • Boston Scientific Corporation (US)
  • Rochester Medical Corporation (US)
  • Johnson & Johnson Private Limited (US)
  • Dispocard GmbH (Germany)
  • Maquet Medical India Private Limited (India)
  • Coloplast (Denmark)

Drivers

  • Increasing Number of Technologically Advanced Devices.
Speak to Analyst Request a Free Sample

Cardiac Catheterization Market Overview


The cardiac catheterization market is anticipated to grow at a high speed in the years to come. The heart catheterization market value is anticipated to grow at a CAGR of 9.2%. This is because of increasing technological advancements in medical devices and the rising number of cardiac diseases among the global population.


Cardiac catheterization refers to a procedure to test the operation of the heart. It is also used to diagnose or cure cardiovascular conditions. The heart catheterization market is fueled by the increase in technologically advanced medical devices, regulatory approvals, geriatric population, alcohol abuse, and the prevalence of cardiac disorders such as cardiac arrhythmias, ventricular fibrillation, and ventricular tachycardia.


Covid-19 Analysis


With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. The heart catheterization market saw a slight downfall post the pandemic, due to the lockdown and physical distancing.


However, the key companies have adopted measures to expand the distribution of cardiac catheters across the globe. Moreover, people are growing aware of cardiac diseases and the need for a heart catheterization. Hence, these factors are expected to boost the growth of the cardiac catheterization market value in the years to come.


Market Dynamics


Drivers


A few factors may drive the growth of the cardiac catheterization market share. There have been increasing cases of cardiac disorders such as cardiac arrhythmias, ventricular fibrillation, and ventricular tachycardia. These cases have contributed to the boost in awareness about healthcare in the people and innovations in the devices. Moreover, the government has been rendering strong support to the development of the market through reimbursement policies and research & development investments. Hence, these factors are expected to accelerate global market growth.


Opportunities


The major companies that account for the largest cardiac catheterization market share are adopting various trends such as new product launches with advanced technology for diagnosis and treatment. There has also been a rise in the average income of the global population, which has fueled the healthcare expenditure. Hence, these factors serve as opportunities for global market growth.


Restraints


There are a few factors that may inhibit the cardiac catheterization market growth. One of the most important of them is the high cost of the catheters and surgical procedures for catheterization. Moreover, these catheters are more likely to come with a few side effects on the patients who undergo the procedure. Hence, these factors may hinder market growth.


Challenges


Some factors that may challenge the key catheterization device providers include the cost of the catheters. They are quite expensive and are not affordable to a majority of patients with cardiac disorders. Moreover, there is a lack of healthcare infrastructure in many places. The population may also not be aware of cardiac diseases such as cardiac arrhythmias and ventricular tachycardia. Hence, these factors challenge the key players of the global market.


Cumulative Growth Analysis


The cardiac catheterization market is anticipated to grow at high speed in the years to come. The heart catheterization market value is anticipated to reach up to USD 20.8 billion over the forecast period, with a CAGR (Compound Annual Growth Rate) of about 9.2%. This is because of increasing technological advancements in medical devices and the rising share of cardiac diseases among the global population.


Value Chain Analysis


People are growing aware of the numerous heart diseases and the need for cardiac catheterization. These catheter devices are growing popular because of their ability to diagnose various heart diseases and cardiovascular conditions. Many key companies of the market have also adopted trends such as innovations and product launches. The government is also supporting market research and development, along with many reimbursement policies for the same. Hence, these factors may fuel the growth of the industry in the global cardiac catheterization market forecast.


Segment Overview


The cardiac catheterization market is classified into many segments such as types and beauty. Listed below are the heart catheterization market segments:


By Types



  • Fractional Flow Reserve

  • Optical Coherence Tomography

  • Intravascular Ultrasound

  • Coronary Angiogram


By Procedures



  • Catheter Ablation

  • Coronary Angioplasty

  • Bipolar Pacing

  • Balloon septostomy

  • Right Heart Catheterization

  • Left Heart Catheterization

  • Others


By Application



  • Heart Attack

  • Cardiac Arrhythmia

  • Coronary Vasospasm

  • Abnormal Stress Test

  • Others


By End-user



  • Hospitals & clinics

  • Others


Regional Analysis


The regional division of the cardiac catheterization market analysis comprises North America, Europe, Asia Pacific, and the rest of the world. Among these regions, the Americas are expected to rule over the global market over the forecast period (2022 – 2027). This is because most of the populations in this region are older and geriatric, with a high share of cardiovascular diseases among adults.


Moreover, obesity and hypertension are other causes of cardiac disorders in the region. Moreover, advanced medical treatment provisions are expected to fuel the demand for a heart catheterization. This region will be followed by Europe, with the second-largest share in the global cardiac catheterization industry. This is because of the demand for better healthcare infrastructure and the initiatives for healthcare reforms by the government in the region.


However, the Asia Pacific region is anticipated to witness the fastest market growth rate over the forecast period. This is because the Asia Pacific comprises a large share of the diabetic population. This is because of the high concentration of the diabetic and geriatric population in the region. Moreover, the government has aided the market growth with favorable reimbursement and insurance policies. However, the Middle East and Africa region are expected to see slow growth due to lack of awareness, availability of treatment facilities, and limited access to them.


Competitive Landscape


The cardiac catheterization industry is dominated by a few companies that play a vital role in the market growth. These heart catheter companies are called key companies of the market. They contribute to the largest share of the market profit.


The companies account for the market profits by adopting various cardiac catheterization market trends such as joint ventures, product launches, company expansions, and procurements. They are innovative catheterization options for patients suffering from cardiac diseases.


Key Players


Below are the key companies that offer cardiac catheterization in the global market, with the location of their headquarters:



  • Jude Medical (US)

  • Medtronic Inc. (US)

  • Becton, Dickinson, and Company (US)

  • Terumo Medical Corporation (Japan)

  • Teleflex Incorporated (US)

  • Edwards Life Sciences Corporation (US)

  • Abbott (US)

  • Boston Scientific Corporation (US)

  • Rochester Medical Corporation (US)

  • Johnson & Johnson Private Limited (US)

  • Dispocard GmbH (Germany)

  • Maquet Medical India Private Limited (India)

  • Coloplast (Denmark)

  • Smiths Medical (US)


Recent Developments 



  • Medtronic Inc. and Boston Scientific Corporation established their regional headquarters and manufacturing plants in Japan, Korea, Singapore, China, and Australia. This is to fuel the cardiac catheterization market in the Asia Pacific.


Report Overview


This report delivers all the information about the growth of the global cardiac catheterization market size in the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected cardiac catheterization market outlook by the year 2027.


Geographically



  • Europe

  • Asia-Pacific

  • North America

  • Middle East & Africa

  • Rest of the world



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   9.2% (2020-2027)
  Base Year   2018
  Forecast Period   2027
  Historical Data   2017
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Procedure, Types, Application, End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boston Scientific Corporation (US), Coloplast (Denmark), Dispocard GmbH (Germany), Becton, Dickinson and Company (US), St. Jude Medical (US), Abbott (US), Johnson & Johnson Private Limited (US), Teleflex Incorporated (US)., Smiths Medical (US), Edwards Life Sciences Corporation (US), Medtronic Inc (US), Rochester Medical Corporation (U.S), Maquet Medical India Private Limited (India), Terumo Medical Corporation (Japan)
  Key Market Opportunities

  • Increasing Awareness of Healthcare, Favorable Reimbursement Policies.
  • Increasing innovations in research and development
  •   Key Market Drivers   Increasing Number of Technologically Advanced Devices.


    Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The cardiac catheterization market is predicted to grow at a 9.2% CAGR between 2018-2027.

    The Americas is predicted to dominate the cardiac catheterization market.

    Increasing prevalence of cardiac diseases, favorable reimbursement policies, and rising awareness of healthcare are boosting market growth.

    Side effects, lack of proper healthcare infrastructure, and high cost may limit market growth.

    It is mostly used to treat and diagnose cardiac arrhythmia, coronary vasospasm, and heart attack.